INCR - intercure.co Trailing Twelve Months Revenue Growth

Public company logo of InterCure (INCR)

Historically, InterCure Ltd. (INCR) relied on excess liquidity and dominance within the Israeli medical cannabis sector. The year-over-year sales volume growth trajectory for the TTM reflects current dynamics, where the value is maintained at 0.00. Outlooks are based on the implementation of AI-driven climate control in greenhouses and the expansion of certified product distribution through European pharmacy chains.

INCR - InterCure Ltd. Sales Growth YoY (TTM) over the range 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for InterCure Ltd. (INCR)

- current price and projected stock value:
- market capitalization statistics:
Summary company analytics:InterCure Ltd.
Original product of Canndoc

Ignoring revenue dynamics creates the risk of overpaying for the asset amid a hidden slowdown in demand. This is critical for InterCure Ltd. (INCR), as business expansion requires significant expenditures on greenhouses and manual labor. The year-over-year sales trajectory (based on TTM) smooths out quarterly noise, calculating the net growth over a rolling year. This indicator distinguishes random spikes from genuine scaling. A steady upward curve confirms operational growth but requires correlation with rising costs.